Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma
Figure 3
Impact of BEV on steroid requirement. Steroid dose is markedly decreased after BEV administration. Paired doses of dexamethasone at initiation and two months after initiation of BEV or recurrence in the No-BEV group demonstrate a marked difference in ability to reduce steroid dosage.
